Slow decision-making by policymakers can contribute to a substantial lag between the availability of lifesaving interventions, such as vaccines, and developing countries’ access to them. This booklet presents a set of advocacy tips, success …

This poster, presented at the 2008 International Pathogenic Neisseria Conference, displays a detailed analysis of long-term surveillance data from Burkina Faso, Mali, and Niger during the past 20 years in order to understand the dynamics of …

The authors of this study, published in the journal Vaccine, analyzed advantages and disadvantages of different ways vaccine manufacturers access new technologies. Among the methods considered were collaborations with academia and research …

Investigators collected stool specimens from Ghanian children with acute gastroenteritis and determined that rotavirus was the most predominant cause in urban northern Ghana. This article was published in BMC Infectious Diseases.

MenAfriVac™ is a new meningococcal A conjugate vaccine developed to prevent meningitis outbreaks in Africa. It was first introduced during the last quarter of 2010 in three West African countries. The authors of this article, published in …

The three-year Africa Routine Immunization System Essentials (ARISE) project, which ended in November 2012, worked to build the evidence base on what drives improvements in routine immunization in Africa. Findings from the project's work complement …

This map of the African continent displays the location of the Meningitis Belt, an area in Africa where a large number of meningitis epidemics occur.

This article, published in Vaccine, reports on a study of the potency of monovalent oral polio vaccine type 3 kept at ambient temperatures during a polio immunization campaign in Chad. The results of the study show that post-campaign …

The vaccine MenAfriVac™ has the potential to confer herd immunity by reducing carriage prevalence of epidemic strains. To better understand this phenomenon, the authors of this article, published in Clinical and Vaccine …

This report highlights a study that uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus vaccine presentations. The results of this study provide insight into …

This fact sheet describes how Project Optimize—a collaboration between the World Health Organization and PATH—and their partners are working with countries to model the impact of changes to vaccine logistics and supply systems on vaccine …

This report summarizes the objectives of PATH's now-inactive Children's Vaccine Program, highlighting the program's earlier activities in several countries in Africa and Asia aimed at increasing access to livesaving vaccines.

To assess the potential impact of rotavirus vaccines in sub-Saharan Africa, researchers reviewed recent published data on rotavirus burden among children aged five years old and circulating serotypes in sub-Saharan Africa. Though many countries …

This poster, presented at the 16th International Pathogenic Neisseria Conference in the Netherlands, discusses a study that aimed to provide preliminary information regarding meningococcal carriage in West Africa and on the effect on …

Partners in Health for Reform Plus, in collaboration with WHO and the Morrocan Ministry of Health, conducted an in-depth study of the costs and financing of immunization, and their report offers options in the areas of program planning, management, …

This study estimates the current and future costs of Ghana's immunization program, including the additional costs proposed for improvements to the program, both to assist planning and to inform the international community about global immunization …

This film in the BBC’s "Kill or Cure?" series uncovers the challenges of preventing and treating cervical cancer in Africa and highlights exciting new opportunities for dramatically reducing the toll of disease. The BBC crew follows Sarah …

Information for parents and health care workers about diseases and vaccines, extensive questions and answers, and charts comparing disease risk versus vaccine risk.

This study, published in PLoS Medicine, provides a clear, quantitative demonstration of the connections that exist between major meningococcal meningitis (MCM) epidemics and regional climate variability in Africa. This statistically robust …

This study, published in PLoS Medicine, aimed to determine how levels of colonization with different bacterial meingococcal serogroups change over time, and how the patterns of disease relate to such changes in the Kassena-Nankana District of …

This article, published in Médecine et Maladies Infectieuses, provides an overview of a cross-sectional, descriptive study to identify strains of Neisseria meningitidis isolated from 2005 to 2007 in Mali. Neisseria meningitidis appeared in 144 …

This fact sheet describes PATH’s work to develop and deploy a software tool called Cold Chain Equipment Manager to help vaccination programs manage equipment requirements, forecast equipment needs, and generate procurement lists. It includes a …

This 68-page manual examines the origin and impact of rumors on immunization programmes in Uganda, Kenya, and Tanzania and provides practical advice about dealing with rumors.

Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria …

Malaria is a leading cause of mortality and morbidity in Mozambique, with nearly three-quarters of the country’s malaria-related deaths occurring in children younger than five years. A malaria vaccine is not yet available, but planning is …